91 related articles for article (PubMed ID: 36792756)
1. PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B.
Wang J; Xiao Z; Li P; Wu C; Li Y; Wang Q; Chen Y; Zhou H; Li Z; Wang Z; Lan Q; Wang Y
Oncogene; 2023 Mar; 42(14):1088-1100. PubMed ID: 36792756
[TBL] [Abstract][Full Text] [Related]
2. Arginine methylation of ALKBH5 by PRMT6 promotes breast tumorigenesis via LDHA-mediated glycolysis.
Han X; Ren C; Jiang A; Sun Y; Lu J; Ling X; Lu C; Yu Z
Front Med; 2024 Apr; 18(2):344-356. PubMed ID: 38466502
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis and experimental validation reveal that CDC20 overexpression promotes bladder cancer progression and potential underlying mechanisms.
Liu Y; Zou SH; Gao X
Genes Genomics; 2024 Apr; 46(4):437-449. PubMed ID: 38438666
[TBL] [Abstract][Full Text] [Related]
4. PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages.
Avasarala S; Wu PY; Khan SQ; Yanlin S; Van Scoyk M; Bao J; Di Lorenzo A; David O; Bedford MT; Gupta V; Winn RA; Bikkavilli RK
Mol Cancer Res; 2020 Jan; 18(1):166-178. PubMed ID: 31619507
[TBL] [Abstract][Full Text] [Related]
5. CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells.
Mao DD; Cleary RT; Gujar A; Mahlokozera T; Kim AH
PLoS One; 2022; 17(6):e0270251. PubMed ID: 35737702
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a first-in-class degrader for the protein arginine methyltransferase 6 (PRMT6).
Yang H; Zhang Q; Zhou S; Hu Z; Tang Q; Li Z; Feng Q; Yu L
Bioorg Chem; 2024 May; 148():107439. PubMed ID: 38754310
[TBL] [Abstract][Full Text] [Related]
7. FAK Inhibition Induces Glioblastoma Cell Senescence-Like State through p62 and p27.
Alza L; Nàger M; Visa A; Cantí C; Herreros J
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32349327
[TBL] [Abstract][Full Text] [Related]
8. The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review.
Xian F; Zhao C; Huang C; Bie J; Xu G
Medicine (Baltimore); 2023 Sep; 102(36):e35038. PubMed ID: 37682144
[TBL] [Abstract][Full Text] [Related]
9. Chimeric PRMT6 protein produced by an endogenous retrovirus promoter regulates cell fate decision in mouse preimplantation embryos†.
Honda S; Hatamura M; Kunimoto Y; Ikeda S; Minami N
Biol Reprod; 2024 Apr; 110(4):698-710. PubMed ID: 38196172
[TBL] [Abstract][Full Text] [Related]
10. Low CDKN1B Expression Associated with Reduced CD8+ T Lymphocytes Predicts Poor Outcome in Breast Cancer in a Machine Learning Analysis.
Kim HS; Noh YK; Min KW; Kim DH
J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38248731
[TBL] [Abstract][Full Text] [Related]
11. PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism.
Sun M; Li L; Niu Y; Wang Y; Yan Q; Xie F; Qiao Y; Song J; Sun H; Li Z; Lai S; Chang H; Zhang H; Wang J; Yang C; Zhao H; Tan J; Li Y; Liu S; Lu B; Liu M; Kong G; Zhao Y; Zhang C; Lin SH; Luo C; Zhang S; Shan C
Acta Pharm Sin B; 2023 Jan; 13(1):157-173. PubMed ID: 36815049
[TBL] [Abstract][Full Text] [Related]
12. The PRMT6/PARP1/CRL4B Complex Regulates the Circadian Clock and Promotes Breast Tumorigenesis.
Yang T; Huang W; Ma T; Yin X; Zhang J; Huo M; Hu T; Gao T; Liu W; Zhang D; Yu H; Teng X; Zhang M; Qin H; Yang Y; Yuan B; Wang Y
Adv Sci (Weinh); 2023 May; 10(14):e2202737. PubMed ID: 36941223
[TBL] [Abstract][Full Text] [Related]
13. A mycobacterial effector promotes ferroptosis-dependent pathogenicity and dissemination.
Qiang L; Zhang Y; Lei Z; Lu Z; Tan S; Ge P; Chai Q; Zhao M; Zhang X; Li B; Pang Y; Zhang L; Liu CH; Wang J
Nat Commun; 2023 Mar; 14(1):1430. PubMed ID: 36932056
[TBL] [Abstract][Full Text] [Related]
14. Critical Roles of Protein Arginine Methylation in the Central Nervous System.
Chang K; Gao D; Yan J; Lin L; Cui T; Lu S
Mol Neurobiol; 2023 Oct; 60(10):6060-6091. PubMed ID: 37415067
[TBL] [Abstract][Full Text] [Related]
15. PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.
Shi Y; Niu Y; Yuan Y; Li K; Zhong C; Qiu Z; Li K; Lin Z; Yang Z; Zuo D; Qiu J; He W; Wang C; Liao Y; Wang G; Yuan Y; Li B
Nat Commun; 2023 Apr; 14(1):1932. PubMed ID: 37024475
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethylation of AMPKα1 by PRMT6 contributes to the formation of phase-separated puncta.
Yoo YJ; Cho G; Kim D; Kim Y; Yun N; Oh YJ
Biochem Biophys Res Commun; 2023 Jul; 666():92-100. PubMed ID: 37178510
[TBL] [Abstract][Full Text] [Related]
17. TRIM6 promotes glioma malignant progression by enhancing FOXO3A ubiquitination and degradation.
Guo J; Wang J; Zhang P; Wen P; Zhang S; Dong X; Dong J
Transl Oncol; 2024 May; 46():101999. PubMed ID: 38759605
[TBL] [Abstract][Full Text] [Related]
18. PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt-β-catenin pathway.
Yu P; Xu T; Ma W; Fang X; Bao Y; Xu C; Huang J; Sun Y; Li G
J Exp Clin Cancer Res; 2024 Apr; 43(1):116. PubMed ID: 38637831
[TBL] [Abstract][Full Text] [Related]
19. circFAM193B interaction with PRMT6 regulates AML leukemia stem cells chemoresistance through altering the oxidative metabolism and lipid peroxidation.
Yang X; Liu J; Liu W; Wu H; Wei Y; Guo X; Jia H; Can C; Wang D; Hu X; Ma D
Leukemia; 2024 May; 38(5):1057-1071. PubMed ID: 38424136
[TBL] [Abstract][Full Text] [Related]
20. PRMT1 in human neoplasm: cancer biology and potential therapeutic target.
Shen S; Zhou H; Xiao Z; Zhan S; Tuo Y; Chen D; Pang X; Wang Y; Wang J
Cell Commun Signal; 2024 Feb; 22(1):102. PubMed ID: 38326807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
